Adlai Nortye (NASDAQ:ANL) Stock Price Up 18.1% – What’s Next?

Shares of Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANLGet Free Report) traded up 18.1% during mid-day trading on Friday . The company traded as high as $15.20 and last traded at $16.1710. 227,864 shares traded hands during mid-day trading, a decline of 62% from the average session volume of 597,355 shares. The stock had previously closed at $13.69.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Adlai Nortye in a report on Wednesday, January 21st. HC Wainwright raised shares of Adlai Nortye from a “neutral” rating to a “buy” rating and set a $16.00 target price on the stock in a report on Friday, February 13th. Leerink Partners assumed coverage on shares of Adlai Nortye in a report on Friday, March 20th. They issued an “outperform” rating and a $23.00 target price on the stock. Finally, Wall Street Zen raised shares of Adlai Nortye to a “hold” rating in a report on Saturday, March 7th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Adlai Nortye currently has a consensus rating of “Hold” and a consensus target price of $19.50.

View Our Latest Analysis on ANL

Adlai Nortye Stock Up 16.9%

The company’s fifty day moving average price is $9.17 and its two-hundred day moving average price is $4.56.

About Adlai Nortye

(Get Free Report)

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.

Featured Stories

Receive News & Ratings for Adlai Nortye Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adlai Nortye and related companies with MarketBeat.com's FREE daily email newsletter.